[go: up one dir, main page]

AU5981599A - Mri contrast agent - Google Patents

Mri contrast agent

Info

Publication number
AU5981599A
AU5981599A AU59815/99A AU5981599A AU5981599A AU 5981599 A AU5981599 A AU 5981599A AU 59815/99 A AU59815/99 A AU 59815/99A AU 5981599 A AU5981599 A AU 5981599A AU 5981599 A AU5981599 A AU 5981599A
Authority
AU
Australia
Prior art keywords
contrast agent
mri contrast
mri
agent
contrast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59815/99A
Inventor
Toshihiro Akaike
Atsushi Maruyama
Masahito Mikawa
Naoto Miwa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU5981599A publication Critical patent/AU5981599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • A61K49/128—Linear polymers, e.g. dextran, inulin, PEG comprising multiple complex or complex-forming groups, being either part of the linear polymeric backbone or being pending groups covalently linked to the linear polymeric backbone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1803—Semi-solid preparations, e.g. ointments, gels, hydrogels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
AU59815/99A 1998-09-17 1999-09-16 Mri contrast agent Abandoned AU5981599A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10263757A JP2000086538A (en) 1998-09-17 1998-09-17 Contrast medium for mri
JP10/263757 1998-09-17
PCT/EP1999/007090 WO2000016811A2 (en) 1998-09-17 1999-09-16 Mri contrast agent

Publications (1)

Publication Number Publication Date
AU5981599A true AU5981599A (en) 2000-04-10

Family

ID=17393868

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59815/99A Abandoned AU5981599A (en) 1998-09-17 1999-09-16 Mri contrast agent

Country Status (3)

Country Link
JP (1) JP2000086538A (en)
AU (1) AU5981599A (en)
WO (1) WO2000016811A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100830A1 (en) * 2001-11-27 2003-05-29 Sheng-Ping Zhong Implantable or insertable medical devices visible under magnetic resonance imaging
DE10311628B4 (en) 2003-03-14 2006-04-13 Siemens Ag imaging
WO2005048987A1 (en) * 2003-11-21 2005-06-02 Fuji Photo Film Co., Ltd. Contrast medium comprising liposomes containing hydrophobic chelate compound
US8299283B2 (en) 2007-09-03 2012-10-30 Kyoto University Contrast agent containing silsesquioxane
JP2012197323A (en) * 2009-07-21 2012-10-18 Univ Of Tokyo Polymer micelle composite for contrasting in mri
KR101398214B1 (en) * 2011-04-06 2014-05-23 주식회사 바이오리더스 Sensitive MRI Contrast Nano Agents Based Ionic Complex Containing Anionic and Cationic Polymer and Preparing Method Thereof
FR3043330B1 (en) * 2015-11-05 2019-06-21 Centre National De La Recherche Scientifique (Cnrs) CONSTRATE AGENTS FOR MEDICAL IMAGING
RU2639390C2 (en) * 2016-04-12 2017-12-21 Юрий Викторович Гольтяпин Medicinal contrast composition
IT201900007647A1 (en) * 2019-05-30 2020-11-30 Univ Degli Studi Di Torino NEW CONTRAST AGENTS FOR MAGNETIC RESONANCE FOR IMAGES
KR102667904B1 (en) * 2021-07-21 2024-05-21 경북대학교 산학협력단 Gadolinium-based compound, mri contrast agent comprising the same
WO2023003409A1 (en) * 2021-07-21 2023-01-26 경북대학교 산학협력단 Gadolinium-based compound and mri contrast agent comprising same
KR102646267B1 (en) * 2021-07-21 2024-03-11 경북대학교 산학협력단 Gadolinium-based compound, mri contrast agent comprising the same
WO2023003408A1 (en) * 2021-07-21 2023-01-26 경북대학교 산학협력단 Gadolinium-based compound and mri contrast agent including same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79559A0 (en) * 1986-07-29 1986-10-31 Univ Ramot Contrast agents for nmr medical imaging
US5554748A (en) * 1989-04-07 1996-09-10 Nycomed Salutar, Inc. Adducts of macrocyclic chelants
US5679810A (en) * 1990-01-19 1997-10-21 Salutar, Inc. Linear oligomeric polychelant compounds
FR2667072B1 (en) * 1990-09-24 1993-08-13 Bioetica Sa TERNARY COMPLEX OF CHITOSANE, CALCIUM IONS AND LIPIDS, METHOD OF PREPARATION AND THEIR APPLICATIONS.
US5514379A (en) * 1992-08-07 1996-05-07 The General Hospital Corporation Hydrogel compositions and methods of use
US5534241A (en) * 1993-07-23 1996-07-09 Torchilin; Vladimir P. Amphipathic polychelating compounds and methods of use
WO1996010359A1 (en) * 1994-10-03 1996-04-11 The Trustees Of The University Of Pennsylvania Chelate complex with high conspicuity for magnetic resonance imaging
IL115670A (en) * 1994-10-21 1999-11-30 Nihon Mediphysics Co Ltd Diagnostic imaging agent
US5801228A (en) * 1995-06-07 1998-09-01 Nycomed Imaging As Polymeric contrast agents for medical imaging
ATA7997A (en) * 1997-01-21 1998-03-15 Bernkop Schnuerch Andreas METHOD FOR PRODUCING CHITOSAN ETHYLENE DIAMINE TETRAACETATE CONJUGATES
NZ500273A (en) * 1997-03-18 2001-12-21 Nihon Schering Kabushiki Kaish Gadolinium (Gd) polymer MRI contrast agent responsive to environmental changes

Also Published As

Publication number Publication date
JP2000086538A (en) 2000-03-28
WO2000016811A3 (en) 2000-11-23
WO2000016811A2 (en) 2000-03-30

Similar Documents

Publication Publication Date Title
AU3485999A (en) Neo-tryptophan
AU5970699A (en) Use
AU3344099A (en) Analgetic agent
AU5981599A (en) Mri contrast agent
AU6413996A (en) Mr contrast agent
AU3437799A (en) City-car
AU3522399A (en) Carvedilol-galenics
AU1554301A (en) Radioprotecting agent
AU3253699A (en) Myxochelines
AU5407599A (en) Sphingolipid-desaturase
ZA987483B (en) Contrast agent
AU8363398A (en) Capotasto
AU5757799A (en) Weed-controlling agents
AU2609599A (en) Sensor-coupling
AU3204999A (en) Futureball
AU9460998A (en) An agitator
AU2069199A (en) Codelets
AU5223199A (en) Bathtub-bathseat
AU1055399A (en) Rollerboard
AU3347599A (en) Aeromobile
AU9347498A (en) Imidazotriazolopyrimidines
AU3194197A (en) Stainblocking agent
AU3819799A (en) Methoximinomethyloxathiazines
AU2840799A (en) 1-phosphanorbornadienes
AU5402999A (en) Mri image-forming

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase